BROLIN JOHNSON: Open Payments
NPI 1265999338 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,442 in 57 payments from 10 companies in 2025. Trend: 2023 $1,188 · 2024 $1,441 · 2025 $1,442
Food & beverage: $1,258Education: $184
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $465 |
| Janssen Biotech, Inc. | 15 | $316 |
| Amgen Inc. | 6 | $155 |
| Novartis Pharmaceuticals Corporation | 5 | $140 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $140 |
| Boston Scientific Corporation | 2 | $113 |
| GENZYME CORPORATION | 2 | $44 |
| Incyte Corporation | 1 | $26 |
| Galderma Laboratories, L.P. | 1 | $25 |
| Saluda Medical Americas, Inc. | 1 | $20 |
Products named: SKYRIZI, TREMFYA, OTEZLA, COSENTYX, General - Pain Management, ILUMYA, Intracept, DUPIXENT.
Industry payments across OR — which companies pay providers there.
